GPI15427 is a potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1), an enzyme that plays a detrimental role during inflammation. It exhibits strong anti-inflammatory effects in rat models of intestinal injury and inflammation, including splanchnic artery occlusion (SAO) shock and dinitrobenzene sulfonic acid (DNBS)-induced colitis. GPI15427 reduces inflammatory cell infiltration, histological damage, and delays the onset of clinical symptoms of inflammation. It also decreases the accumulation of poly(ADP-ribose) in the ileum and colon of treated rats. These findings indicate that GPI15427 may be used for the treatment of intestinal ischemia and inflammation.